A client on lamotrigine presents with which finding that warrants withholding and notifying provider?

A client on lamotrigine presents with which finding that warrants withholding and notifying provider?

• A. Dizziness
• B. Headache
• C. Skin rash
• D. Nausea

Answer: (C)

The main concept is recognizing a potentially life-threatening dermatologic reaction risk with lamotrigine. A skin rash is the red flag that requires stopping the medication and notifying the provider because it can progress to Stevens-Johnson syndrome, especially in the early weeks of therapy. Early rash may be benign, but progression to severe mucous membrane involvement or widespread blistering has serious consequences, so the safest action is to withhold lamotrigine and seek medical guidance promptly. In contrast, dizziness, headache, or nausea are common, less dangerous side effects that do not by themselves mandate stopping therapy. Remember to educate patients to seek help if a rash appears, and to report any fever, malaise, or mucosal symptoms, which would require urgent evaluation.

The main concept is recognizing a potentially life-threatening dermatologic reaction risk with lamotrigine. A skin rash is the red flag that requires stopping the medication and notifying the provider because it can progress to Stevens-Johnson syndrome, especially in the early weeks of therapy. Early rash may be benign, but progression to severe mucous membrane involvement or widespread blistering has serious consequences, so the safest action is to withhold lamotrigine and seek medical guidance promptly.

In contrast, dizziness, headache, or nausea are common, less dangerous side effects that do not by themselves mandate stopping therapy. Remember to educate patients to seek help if a rash appears, and to report any fever, malaise, or mucosal symptoms, which would require urgent evaluation.